Table 28 In vitro anticancer activity of the synthesized compound
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compound | IC50 (µM) | ||
|---|---|---|---|
CNE2 | KB | Cal27 | |
b32 | 1.92 ± 0.13 | 3.72 ± 0.54 | 1.97 ± 0.51 |
Doxorubicin | 2.12 ± 0.56 | 3.04 ± 0.87 | 1.56 ± 0.64 |